SCHEMBL21397670

SCHEMBL21397670

CCCC1(CCC(C)C)Cc2ccccc2C1N

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 3/20 0.33
PRCP P42785 1/20 0.32
ADRA2B P18089 2/20 0.31
ADRA2C P18825 2/20 0.31
CHRM1 P11229 1/20 0.31
DRD2 P14416 1/20 0.31
CHRM3 P20309 1/20 0.31
HTR2C P28335 1/20 0.31
ADRA1A P35348 1/20 0.31
HRH1 P35367 1/20 0.31
DRD3 P35462 1/20 0.31
KCNH2 Q12809 1/20 0.31
KDM1A O60341 2/20 0.31
MAOA P21397 2/20 0.31
MAOB P27338 2/20 0.31
ADRA2A P08913 1/20 0.30
ADRA1B P35368 1/20 0.30
OPRM1 P35372 1/20 0.30
OPRK1 P41145 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21397337 0.90 HTR2A (0.37) HTR2APRCPADRA2BADRA2CHTR2C
SCHEMBL21397653 0.84 HTR2A (0.35) HTR2AADRA2BADRA2CHTR2CHRH1
SCHEMBL21397676 0.80 KDM1A (0.31) HTR2AADRA2BADRA2CKDM1AMAOA
SCHEMBL21397647 0.80 DRD2 (0.36) HTR2AADRA2BADRA2CDRD2ADRA1A
SCHEMBL21397401 0.80 KDM1A (0.31) HTR2AADRA2BADRA2CKDM1AMAOA
SCHEMBL21397254 0.79 DRD2 (0.32) DRD2DRD3
SCHEMBL21397678 0.77 HTR2A (0.39) HTR2AADRA2BADRA2CHTR2CHRH1
SCHEMBL21397520 0.76 DRD2 (0.38) DRD2OPRK1
SCHEMBL22393599 0.71 HTR2A (0.42) HTR2APRCPKDM1AOPRM1OPRK1
SCHEMBL22393733 0.69 HTR2A (0.38) HTR2APRCPADRA2BADRA2CCHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019183367-A1 SHP2 PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF RELAY THERAPEUTICS, INC. (US) 2019-09-26 WO disclosed